Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Total Current Liabilities (2018 - 2026)

Alector's (ALEC) quarterly Total Current Liabilities came in at $34.2 million in Q2 2026, down 59.41% year-over-year from $84.4 million in Q2 2025, and down 16.43% quarter-over-quarter from $41.0 million in Q1 2026.

Analysis

Alector (ALEC) Total Current Liabilities (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Total Current Liabilities for 9 consecutive years, with $34.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Current Liabilities fell 59.41% year-over-year to $34.2 million in Q2 2026; TTM through Jun 2026 was $34.2 million, a 59.41% decrease from a year earlier, with the FY2025 full-year figure at $69.5 million, down 44.42% from the prior year.
  • Total Current Liabilities was $34.2 million for Q2 2026 at Alector, down from $41.0 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $177.9 million in Q4 2023 and troughed at $34.2 million in Q2 2026.
  • A 5-year average of $117.3 million and a median of $128.7 million in 2023 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities jumped 123.03% in 2022 and slumped 62.68% in 2026, its largest moves.
  • Over 5 years, Total Current Liabilities stood at $93.8 million in 2022, then surged by 89.69% to $177.9 million in 2023, then retreated by 29.72% to $125.1 million in 2024, then plunged by 44.42% to $69.5 million in 2025, then plunged by 50.74% to $34.2 million in 2026.
  • The last three Total Current Liabilities figures came in at $34.2 million (Q2 2026), $41.0 million (Q1 2026), and $69.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.58 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 1.51 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 3.92 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 438.74 Mn
10 Alector 274.68 Mn 101.88 Mn - 34.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.24 Mn
Mar 31, 2026 40.97 Mn
Dec 31, 2025 69.50 Mn
Sep 30, 2025 79.96 Mn
Jun 30, 2025 84.35 Mn
Mar 31, 2025 109.77 Mn
Dec 31, 2024 125.06 Mn
Sep 30, 2024 142.53 Mn
Jun 30, 2024 147.68 Mn
Mar 31, 2024 164.92 Mn
Dec 31, 2023 177.95 Mn
Sep 30, 2023 155.40 Mn
Jun 30, 2023 132.27 Mn
Mar 31, 2023 99.30 Mn
Dec 31, 2022 93.81 Mn
Sep 30, 2022 160.89 Mn
Jun 30, 2022 149.41 Mn
Mar 31, 2022 142.88 Mn
Dec 31, 2021 139.56 Mn
Sep 30, 2021 132.82 Mn